Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

UNITED THERAPEUTICS Corp Director's Dealing 2012

Aug 2, 2012

30320_dirs_2012-08-02_fca44881-6259-428e-a0e8-5a894a659208.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: UNITED THERAPEUTICS Corp (UTHR)
CIK: 0001082554
Period of Report: 2012-08-01

Reporting Person: PATUSKY CHRISTOPHER (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-08-01 Common Stock M 2000 $27.70 Acquired 2000 Direct
2012-08-01 Common Stock S 2000 $54.6945 Disposed 0 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-08-01 Stock Options $27.70 M 2000 Disposed 2016-06-26 Common Stock (2000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1300 Indirect

Footnotes

F1: This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.

F2: Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.

F3: This transaction was executed in multiple trades at prices ranging from $54.69 to $54.75. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.